CDK8-IN-19

CAT: 0931-T210596-01Size: 10 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T210596-01Size:10 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Target

PI3K, CDK

Related Pathways

PI3K/Akt/mTOR signaling, Cell Cycle/Checkpoint

Bioactivity

CDK8-IN-19 (Compound 3d) is a CDK8 inhibitor with an IC50 of 25.08 nM. It exhibits broad-spectrum anticancer activity, showing effectiveness against leukemia, melanoma, and breast cancer, while demonstrating no significant cytotoxicity to normal Vero cells (mean IC50 values are 2.87, 3.65, 3.79, and 45.48 μM, respectively) .

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Related Products

Catalog	Name
T22633-01	CDK8/19-IN-51
T10739-01	CDK8/19-IN-1
T204986-01	CDK8/19-IN-3
T88262-01	CDK8/19-IN-2
T10740-01	CDK8-IN-1
T204689-01	CDK8-IN-17
T72048-01	CDK8-IN-12
T62354-01	CDK8-IN-7
T17305-01	CDK8-IN-4
T61742-01	CDK8-IN-11

Alternative Products

Catalog	Name
HY-176282	CDK8-IN-19
HY-111427-01	CDK8/19-IN-1
HY-168846	CDK8/19-IN-3
HY-158377	CDK8/19-IN-2
BUP21189-01	CDK8/19-IN-51
A19857-1	Anti-CDK8/19 Antibody
A19986-50	CDK8/19-IN-1 50mg
A19986-25	CDK8/19-IN-1 25mg
A19986-10	CDK8/19-IN-1 10mg
A19986-1	CDK8/19-IN-1 1mg

CDK8-IN-19

Related Products

Alternative Products

Popular Products